Share the Video:

Proactive harm reduction by preparing set, setting, and substance

Mitchell Gomez, Phoenix aka Mohawk Greene

Join two harm reduction superheroes reflecting on the theory and practice of risk mitigation and benefit maximization. This fast-paced, forward-thinking and practical address will consider the power of mindset (set), physical and environmental conditions (setting), and the very drugs themselves (substance). Attendees will be offered novel and nuanced perspectives focused on empowering individuals to better understand the context of their drug use, ensuring safer and more intentional experiences through personal awareness and systemic change.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Giving and growth: the role of philanthropic funding in the psychedelic sector

Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.

Sandy Samberg

PS2023 Harm Reduction LSD Policy and Advocacy Psychedelic Science Research Social Justice

Underground History and Overground Future

William Leonard Pickard, once a prominent figure in the drug world, served 20 years in prison for LSD production and now works as a senior advisor for various organizations. His

William Leonard Pickard, Vince Kadlubek

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Designing a post-prohibition future

Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.

Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn

PS2023 Health Equity Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Psychedelic social equity, criminal justice, and sentencing reform

Visionary advocates, activists, and policy experts discuss rectifying historical injustices and disparities from psychedelic criminalization. Conversations focus on social equity, criminal justice reform, and sentencing for legal infrastructure changes.

Kellen Russoniello, Rachel Knox, Sia Henry

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Visionary approaches: psychedelic policy in a global context

International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.

Steve Rolles, Kasia Malinowska

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

Safety and accountability in psychedelic communities

Dr. Smith and Dr. Jones explore advancements in psychedelic research and therapy, highlighting key findings and implications for mental health treatment.

Hannah McLane, Brad Adams

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Healing for All Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

State Policy Reform: A Vision for Expanding Access to Psychedelics

Graham Boyd highlights recent ballot victories in Oregon and Colorado, emphasizing the potential for broad psychedelic access and significant policy reform advancements across the United States. Boyd discusses state legislatures'

Graham Boyd

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

Proactive harm reduction by preparing set, setting, and substance

Become a MAPS Member with a monthly donation

Related Videos